Vaginal Self-Sampling for Human Papillomavirus Infection as a Primary Cervical Cancer Screening Tool in a Haitian Population.

dc.contributor.author

Boggan, Joel C

dc.contributor.author

Walmer, David K

dc.contributor.author

Henderson, Gregory

dc.contributor.author

Chakhtoura, Nahida

dc.contributor.author

McCarthy, Schatzi H

dc.contributor.author

Beauvais, Harry J

dc.contributor.author

Smith, Jennifer S

dc.coverage.spatial

United States

dc.date.accessioned

2017-05-27T17:52:52Z

dc.date.available

2017-05-27T17:52:52Z

dc.date.issued

2015-11

dc.description.abstract

BACKGROUND: Human papillomavirus (HPV) testing as primary cervical cancer screening has not been studied in Caribbean women. We tested vaginal self-collection versus physician cervical sampling in a population of Haitian women. METHODS: Participants were screened for high-risk HPV with self-performed vaginal and clinician-collected cervical samples using Hybrid Capture 2 assays (Qiagen, Gaithersburg, MD). Women positive by either method then underwent colposcopy with biopsy of all visible lesions. Sensitivity and positive predictive value were calculated for each sample method compared with biopsy results, with κ statistics performed for agreement. McNemar tests were performed for differences in sensitivity at ≥cervical intraepithelial neoplasia (CIN)-I and ≥CIN-II. RESULTS: Of 1845 women screened, 446 (24.3%) were HPV positive by either method, including 105 (5.7%) only by vaginal swab and 53 (2.9%) only by cervical swab. Vaginal and cervical samples were 91.4% concordant (κ = 0.73 [95% confidence interval, 0.69-0.77], P < 0.001). Overall, 133 HPV-positive women (29.9%) had CIN-I, whereas 32 (7.2%) had ≥CIN-II. The sensitivity of vaginal swabs was similar to cervical swabs for detecting ≥CIN-I (89.1% vs. 87.9%, respectively; P = 0.75) lesions and ≥CIN-II disease (87.5% vs. 96.9%, P = 0.18). Eighteen of 19 cases of CIN-III and invasive cancer were found by both methods. CONCLUSIONS: Human papillomavirus screening via self-collected vaginal swabs or physician-collected cervical swabs are feasible options in this Haitian population. The agreement between cervical and vaginal samples was high, suggesting that vaginal sample-only algorithms for screening could be effective for improving screening rates in this underscreened population.

dc.identifier

https://www.ncbi.nlm.nih.gov/pubmed/26462192

dc.identifier

00007435-201511000-00013

dc.identifier.eissn

1537-4521

dc.identifier.uri

https://hdl.handle.net/10161/14596

dc.language

eng

dc.publisher

Ovid Technologies (Wolters Kluwer Health)

dc.relation.ispartof

Sex Transm Dis

dc.relation.isversionof

10.1097/OLQ.0000000000000345

dc.subject

Adolescent

dc.subject

Adult

dc.subject

Cervical Intraepithelial Neoplasia

dc.subject

DNA, Viral

dc.subject

Early Detection of Cancer

dc.subject

Feasibility Studies

dc.subject

Female

dc.subject

Haiti

dc.subject

Humans

dc.subject

Mass Screening

dc.subject

Papillomaviridae

dc.subject

Papillomavirus Infections

dc.subject

Predictive Value of Tests

dc.subject

Self Care

dc.subject

Sensitivity and Specificity

dc.subject

Specimen Handling

dc.subject

Uterine Cervical Neoplasms

dc.subject

Vaginal Smears

dc.title

Vaginal Self-Sampling for Human Papillomavirus Infection as a Primary Cervical Cancer Screening Tool in a Haitian Population.

dc.type

Journal article

duke.contributor.orcid

Boggan, Joel C|0000-0003-3564-2807

duke.contributor.orcid

Walmer, David K|0000-0003-4582-9333

pubs.author-url

https://www.ncbi.nlm.nih.gov/pubmed/26462192

pubs.begin-page

655

pubs.end-page

659

pubs.issue

11

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Duke

pubs.organisational-group

Institutes and Provost's Academic Units

pubs.organisational-group

Medicine

pubs.organisational-group

Medicine, General Internal Medicine

pubs.organisational-group

School of Medicine

pubs.publication-status

Published

pubs.volume

42

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Sex Transm Dis manuscript post-referee.doc
Size:
157.5 KB
Format:
Microsoft Word
Description:
Accepted version